We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Union Pacific
UNP
$183B
| $3.79M | 0.01% |
45,100
-854
| -2% | -$67.6K |
|
352
GSK
GSK
$103B
| $3.76M | 0.01% |
56,399
+334
| +0.6% | +$21.7K |
|
353
Biogen
BIIB
$29.9B
| $3.76M | 0.01% |
13,454
-851
| -6% | -$220K |
|
354
Honeywell
HON
$77.1B
| $3.76M | 0.01% |
45,812
+1,495
| +3% | +$117K |
|
355
Sysco
SYY
$39.7B
| $3.7M | 0.01% |
102,621
-7,408
| -7% | -$250K |
|
356
Enterprise Products Partners
EPD
$83.8B
| $3.67M | 0.01% |
110,792
-3,998
| -3% | -$125K |
|
|
CVT
357
DELISTED
CVENT, INC.
CVT
| $3.67M | 0.01% |
100,886
+7,907
| +9% | +$267K |
|
|
LO
358
DELISTED
LORILLARD INC COM STK
LO
| $3.56M | 0.01% |
70,183
+372
| +0.5% | +$18.5K |
|
359
Invesco
IVZ
$13.3B
| $3.55M | 0.01% |
+97,615
| New | +$3.31M |
|
|
MEAS
360
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $3.53M | 0.01% |
58,180
+442
| +0.8% | +$24.5K |
|
|
ELME
361
Elme Communities
ELME
$132M
| $3.5M | 0.01% |
149,785
-10,277
| -6% | -$254K |
|
|
KMG
362
DELISTED
KMG Chemicals Inc
KMG
| $3.47M | 0.01% |
205,564
+5,033
| +3% | +$97.5K |
|
363
Eli Lilly
LLY
$1.07T
| $3.41M | 0.01% |
66,895
-2,800
| -4% | -$140K |
|
364
Jacobs Solutions
J
$15.9B
| $3.4M | 0.01% |
65,248
+30,345
| +87% | +$1.5M |
|
365
Under Armour
UAA
$3B
| $3.39M | 0.01% |
156,326
+70,807
| +83% | +$1.44M |
|
366
eBay
EBAY
$48.6B
| $3.38M | 0.01% |
146,416
+73,727
| +101% | +$1.63M |
|
367
Genworth Financial
GNW
$3.8B
| $3.38M | 0.01% |
217,524
| – | – |
|
|
CTXS
368
DELISTED
Citrix Systems Inc
CTXS
| $3.34M | 0.01% |
66,358
-6,758,678
| -99% | -$322M |
|
369
Johnson Controls International
JCI
$87.5B
| $3.27M | 0.01% |
60,890
+5,436
| +10% | +$268K |
|
370
Ametek
AME
$55.5B
| $3.27M | 0.01% |
62,079
-3,528
| -5% | -$170K |
|
371
Flowers Foods
FLO
$1.64B
| $3.27M | 0.01% |
152,311
-4,050
| -3% | -$91.4K |
|
372
Corning
GLW
$126B
| $3.22M | 0.01% |
180,452
-24,528
| -12% | -$404K |
|
373
White Mountains Insurance
WTM
$5.47B
| $3.21M | 0.01% |
5,320
| – | – |
|
374
iShares Biotechnology ETF
IBB
$9.31B
| $3.18M | 0.01% |
42,021
-84
| -0.2% | -$5.96K |
|
375
Hercules Capital
HTGC
$2.94B
| $3.16M | 0.01% |
192,900
-4,400
| -2% | -$71K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.